Boston University
A potential approach for treating chronic pain in neuroblastoma patients
Abstract
dc:description.abstractNeuroblastoma is the most common malignancy diagnosed in the first year of life. The complexity of neuroblastoma cases and with the majority of cases being classified as high-risk, the prognosis is unfavorable and the efficacy of current therapies is limited. The difficulties with treatment can prevent many patients with neuroblastoma from finding relief from the neuropathic pain. This study explores the expression of histone deacetylase genes involved in neuropathic pain, hdac1, hdac4, and hdac6 in a zebrafish model for neuroblastoma. The expression of hdac1 and hdac6 was found to decrease in the neuroblastoma model of zebrafish. In the hindbrain and spinal cord, the expression of hdac4 and hdac6 contrasted with each other. In the zebrafish hindbrain, hdac4 expression was elevated and there were lower levels of hdac6 expression. The spinal cord had reduced expression of hdac4 and increased expression of hdac6. The changes in expression may be attributed to the long-term stress from chronic pain in the zebrafish model of neuroblastoma or for neuroprotection from inflammatory signaling. Although a significant relationship was found between neuroblastoma and hdac expression, further studies that include different testing methods and a positive pain model are needed to clarify this relationship.
Degree
thesis:*- Name thesis:degree_name
- Master of Science
- Level thesis:degree_level
- masters
- Discipline thesis:degree_discipline
- Medical Sciences
- Grantor
- Boston University
- Year dc:date.issued
- 2025
Author and committee
dc:creator, dc:contributor.*- Author dc:creator
-
- Mosharraf, Marfia
- Advisors dc:contributor.advisor
-
- Feng, Hui
- Zachariou, Venetia
Subjects
dc:subject × 1Rights
- Language dc:language.iso
- en_US
Identifiers
dc:identifier.*- Handle dc:identifier.uri
- https://hdl.handle.net/2144/53185